|
| 37984795 | Pulmonary Infiltrates With Hypereosinophilia. | J Allergy Clin Immunol Pract | 2024 |
| 37951310 | Mepolizumab incompletely suppresses clinical flares in a pilot study of episodic angioedema with eosinophilia. | J Allergy Clin Immunol | 2024 |
| 36355182 | Correction to: No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds. | Parasitol Res | 2023 |
| 37487654 | Distinct CRTH2+CD161+ (peTh2) memory CD4+ T-cell cytokine profiles in food allergy and eosinophilic gastrointestinal disorders. | Clin Exp Allergy | 2023 |
| 37507068 | Biologics and Hypereosinophilic Syndromes: Knowledge Gaps and Controversies. | J Allergy Clin Immunol Pract | 2023 |
| 37285821 | False-Negative Testing for FIP1L1::PDGFRA by Fluorescence in situ Hybridization Is a Frequent Cause of Diagnostic Delay. | Acta Haematol | 2023 |
| 37336228 | Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial. | Lancet Gastroenterol Hepatol | 2023 |
| 36652685 | Genomics of PDGFR-rearranged hypereosinophilic syndrome. | Blood Adv | 2023 |
| 36621605 | Resolution of hypereosinophilic syndrome following resection of a schwannoma. | J Allergy Clin Immunol Pract | 2023 |
| 36936748 | Cases of Loiasis Among a Congolese Family: Screening for Loiasis Among Newly Arrived Refugees From Endemic Areas. | J Nurse Pract | 2023 |
| 35971862 | Urine eosinophil-derived neurotoxin: A potential marker of activity in select eosinophilic disorders. | Allergy | 2023 |
| 35080202 | Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort. | Am J Gastroenterol | 2022 |
| 35636689 | Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis. | J Allergy Clin Immunol Pract | 2022 |
| 35526864 | The Broad Spectrum of Eosinophilic Disorders. | J Allergy Clin Immunol Pract | 2022 |
| 35753512 | Clinical exome sequencing of 1000 families with complex immune phenotypes: Toward comprehensive genomic evaluations. | J Allergy Clin Immunol | 2022 |
| 36485140 | Approach to the patient with suspected hypereosinophilic syndrome. | Hematology Am Soc Hematol Educ Program | 2022 |
| 35905725 | Rapid GPR183-mediated recruitment of eosinophils to the lung after Mycobacterium tuberculosis infection. | Cell Rep | 2022 |
| 36066741 | No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds. | Parasitol Res | 2022 |
| 36225210 | Recent advances in understanding the role of eosinophils. | Fac Rev | 2022 |
| 35914689 | Changes in Onchocerciasis Ov16 IgG4 Rapid Diagnostic Test Results Over One-Month Follow-up: Lessons for Reading Timeframe and Decision-Making. | Am J Trop Med Hyg | 2022 |
| 35226866 | Comparison of Different Sampling Methods to Catch Lymphatic Filariasis Vectors in a Sudan Savannah Area of Mali. | Am J Trop Med Hyg | 2022 |
| 35283330 | Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease. | J Allergy Clin Immunol Pract | 2022 |
| 35248766 | COVID-19 infection in hypereosinophilic syndrome: A survey-based analysis. | J Allergy Clin Immunol Pract | 2022 |
| 35181548 | An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes. | J Allergy Clin Immunol Pract | 2022 |
| 35085569 | Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study. | Gastroenterology | 2022 |
| 32910141 | A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa loa Infection. | Clin Infect Dis | 2021 |
| 33714638 | Hypereosinophilic syndromes - An enigmatic group of disorders with an intriguing clinical spectrum and challenging treatment. | Blood Rev | 2021 |
| 34347010 | Eosinophils are part of the granulocyte response in tuberculosis and promote host resistance in mice. | J Exp Med | 2021 |
| 34165616 | Eosinophils and helminth infection: protective or pathogenic? | Semin Immunopathol | 2021 |
| 34112494 | Do rural health disparities affect prevalence data in pediatric eosinophilic esophagitis? | J Allergy Clin Immunol Pract | 2021 |
| 32055862 | Infection-associated Immune Perturbations Resolve 1 Year Following Treatment for Loa loa. | Clin Infect Dis | 2021 |
| 33316460 | Successful pregnancy in the setting of eosinophil depletion by benralizumab. | J Allergy Clin Immunol Pract | 2021 |
| 33476787 | Remission of cold-agglutinin autoimmune hemolytic anemia and hypereosinophilic syndrome with rituximab therapy. | J Allergy Clin Immunol Pract | 2021 |
| 33289025 | Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic Areas. | Clin Infect Dis | 2021 |
| 31165855 | A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa-coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon. | Clin Infect Dis | 2020 |
| 32059870 | Platelet-derived growth factor receptor-alpha-positive myeloid neoplasm presenting as eosinophilic gastrointestinal disease. | J Allergy Clin Immunol Pract | 2020 |
| 31977298 | Contributions of Eosinophils to Human Health and Disease. | Annu Rev Pathol | 2020 |
| 31676244 | Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study. | Lancet Infect Dis | 2020 |
| 33085861 | Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis. | N Engl J Med | 2020 |
| 32659786 | Glucocorticoid-induced eosinopenia results from CXCR4-dependent bone marrow migration. | Blood | 2020 |
| 32678342 | A new dawn for eosinophils in the tumour microenvironment. | Nat Rev Cancer | 2020 |
| 32956756 | Efficacy and safety of mepolizumab in hypereosinophilic syndrome: AÂ phase III, randomized, placebo-controlled trial. | J Allergy Clin Immunol | 2020 |
| 32416262 | Symptom assessment in hypereosinophilic syndrome: Toward development of a patient-reported outcomes tool. | J Allergy Clin Immunol Pract | 2020 |
| 32344186 | Single-Organ and Multisystem Hypereosinophilic Syndrome Patients with Gastrointestinal Manifestations Share Common Characteristics. | J Allergy Clin Immunol Pract | 2020 |
| 32251643 | Pulmonary Eosinophilic Granulomatosis with Polyangiitis Has IgG4 Plasma Cells and Immunoregulatory Features. | Am J Pathol | 2020 |
| 30690753 | Siglec-7 on peripheral blood eosinophils: Surface expression and function. | Allergy | 2019 |
| 31657082 | Mechanisms of glucocorticoid resistance in hypereosinophilic syndromes. | Clin Exp Allergy | 2019 |
| 31655098 | Advances in eosinophilic diseases in 2018. | J Allergy Clin Immunol | 2019 |
| 30861060 | Loa loa Microfilariae in Skin Snips: Consequences for Onchocerciasis Monitoring and Evaluation in L. loa-Endemic Areas. | Clin Infect Dis | 2019 |
| 30943337 | Benralizumab for <i>PDGFRA</i>-Negative Hypereosinophilic Syndrome. | N Engl J Med | 2019 |